Circulating tumor DNA dynamics during induction therapy. (A) Qualitative ctDNA response to induction therapy after 1 cycle, after 2 cycles, and at the end of induction therapy. (B) Quantitative ctDNA response after the bortezomib window and after 1 cycle, after 2 cycles, and at the end of induction therapy.